Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: clinical trial

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

Promising OIT Results from UNC Phase II Trial

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

Follow Us

Your School On Our Map

Put Your School on the Map